Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

03-11-2022, 01:10 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,104	Ribociclib plus endocrine therapy offers survival benefit for postmenopausal patients A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive (HR+) human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 02:48 PM.

free webpage hit counter